Table 3.
Outcomes of all treated liver lesions
| Entire cohort | General anesthesia group | Midazolam group | Propofol group | P value | |
|---|---|---|---|---|---|
| Number of patients | 90 | 16 | 25 | 49 | |
| Number of lesions | 171 | 35 | 42 | 94 | |
| Number of procedures | 114 | 22 | 32 | 60 | |
| Median follow-up after each procedure (months)* | 8.9 (14.1) | 8.4 (17.6) | 23.3 (26.8) | 6.5 (6.6) | < 0.001§ |
| Local tumor progression (LTP; no. of lesions) | 25 (14.6%) | 2 (5.7%) | 19 (45.2%) | 4 (4.3%) | < 0.001‡ |
| Time-to-local tumor progression | |||||
| Median for all lesions (months; 95% CI)* | Not reached | Not reached | Not reached | Not reached | NA |
| Mean time to detection of LTP† | 5.6 ± 4.3 | 5.7 ± 3.1 | 6.1 ± 4.8 | 3.6 ± 0.7 | 0.230§ |
| Repeat sessions (no. of re-ablated lesions) | 18 (72.0%) | 1 (5.6%) | 14 (77.8%) | 3 (16.7%) | 0.769‡ |
Statistics are reported as number (with or without percentage; %)
NA not applicable
*median (interquartile range, IQR) or †mean (standard deviation, ± SD)
‡Pearson χ2 test between groups; §Kruskal–Wallis test